SCHEMBL463338

SCHEMBL463338

CC(C)CNc1cc(Cl)nn2c(-c3ccc(C(=O)N(C)Cl)cc3)cnc12

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TTK P33981 12/20 0.53
FYN P06241 3/20 0.46
IKBKB O14920 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
ERN1 O75460 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15559752 0.88 TTK (0.55) TTKFYNERN1
SCHEMBL10279180 0.87 TTK (0.56) TTKFYNMKNK1ERN1
SCHEMBL10279181 0.86 TTK (0.59) TTKFYNMKNK1ERN1
SCHEMBL10279183 0.85 TTK (0.58) TTKFYNMKNK1
SCHEMBL104538 0.82 TTK (0.77) TTK
SCHEMBL470209 0.81 TTK (0.56) TTKFYNMKNK1ERN1
SCHEMBL463339 0.78 TTK (0.48) TTKFYNMKNK1ERN1
SCHEMBL470132 0.76 TTK (0.46) TTKFYNIKBKBERN1
SCHEMBL470013 0.76 CYP1A2 (0.54) TTKFYNIKBKB
SCHEMBL462985 0.76 TTK (0.64) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP claimed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO claimed